I assume you mean't additional coverage. With the CMS 2014 proposal limiting graft payments to 840, I would expect Mimedx to have coverage under all 9 Medicare regions asap. I would expect that CMS desires the competition within the class in order for their proposals to be somewhat effective. From there cvg should snowball. We are talking about MDXG providing significant cost savings to the entire system both government and private payers. Significant increased revenue potential.